ANTIGEN AND ANTIBODY FOR HEPATITIS C VIRUS (HCV AG/ANTI-HCV) - ANVISA Registration 10287411676

Access comprehensive regulatory information for ANTIGEN AND ANTIBODY FOR HEPATITIS C VIRUS (HCV AG/ANTI-HCV) in Brazil's medical device market through Pure Global AI's free database. This Risk Class IV medical device is registered under ANVISA number 10287411676 and manufactured by ROCHE DIAGNOSTICS GMBH. The registration is held by ROCHE DIAGNÓSTICA BRASIL LTDA with validity until Sep 25, 2033.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 similar products found using AI-powered semantic search, 2 companies making the same product including BIO-RAD, DIASORIN ITALIA S.P.A. UK BRANCH, and 4 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.